Clinical trial
Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients…
NCT00004165 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00004165 |
|---|---|
| Title | Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma |
| Official title | Stem Cell Transplant as Standard Therapy for Symptomatic Multiple Myeloma |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, melphalan, peripheral blood stem cell transplantation |
| Start date | Oct 1, 1999 |
| Primary completion | Aug 1, 2003 |
| Completion | Aug 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 6, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: